Kon‐Siong G. Jie - Concepedia

Author

Kon‐Siong G. Jie

Also Known As

A Jie, Asiong Jie, Jeffrey Keuren, K. Jie, Kon-Siong G Jie, Kon-Siong G. Jie, Kon-Siong Jie, Kon‐Siong G. Jie, Kon‐Siong Jie

Publications

Citations

H-Index

Concepts

All Affiliations

Zuyderland Medisch Centrum Maastricht University Maastricht University Medical Centre Haga Hospital Radboud University Nijmegen

About

Kon‐Siong G. Jie is an author at Zuyderland Medisch Centrum specializing in medicine, hematology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2K
2	Health Sciences	5	5	1.3K
3	Public Health	3	3	348
4	Clinical Nutrition	1	1	168
5	Emergency Medicine	1	1	212

Kon‐Siong G. Jie

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study Philippe Moreau, Michel Attal, Cyrille Hulin, The Lancet Hematological MalignancyRadiation OncologyMedicineImmunologyHematology	2019	922
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma Henk M. Lokhorst, Bronno van der Holt, Sonja Zweegman, Blood	2009	275
Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial Pascale Notten, Arina J. ten Cate‐Hoek, Carsten W. K. P. Arnoldussen, The Lancet Haematology Pulmonary EmbolismThrombosisVenous ThrombosisCardiovascular DiseaseMedicine	2019	212
Effect of food composition on vitamin K absorption in human volunteers Birgit L. M. G. Gijsbers, Kon‐Siong G. Jie, Cees Vermeer British Journal Of Nutrition NutritionNutraceutical IngredientVitamin K AbsorptionVitamin KExperimental Nutrition	1996	168
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial Philippe Moreau, Cyrille Hulin, Aurore Perrot, The Lancet Oncology Hematological MalignancyMedicineAutologous Stem-cell TransplantImmunologyHematology	2021	167
Apd in paget's disease of bone role of the mononuclear phagocyte system? O. L. M. Bijvoet, W. B. Frijlink, Kon‐Siong G. Jie, Arthritis & Rheumatism Bone DiseaseRheumatologyAutoimmune DiseaseDisease MechanismPathogenesis	1980	133
Vitamin K intake and osteocalcin levels in women with and without aortic atherosclerosis: a population-based study Kon‐Siong G. Jie, Michiel L. Bots, Cees Vermeer, Atherosclerosis Vitamin K AntagonistsNutritionMetabolic SyndromePopulation-based StudyCardiovascular Disease	1995	107
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme Lieke H. van der Helm, Canan Alhan, Pierre W. Wijermans, British Journal of Haematology	2011	106
Vitamin K-induced changes in markers for osteoblast activity and urinary calcium loss Marjo H.J. Knapen, Kon‐Siong G. Jie, Karly Hamuly�k, Calcified Tissue International UrologyBone HealthUrinary Calcium LossMedicinePhysiology	1993	105
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial Philippe Moreau, Cyrille Hulin, Aurore Perrot, The Lancet Oncology Hematological MalignancyMedicineDaratumumab MaintenanceHematologyMyeloid Neoplasia	2024	94

Page 1